We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$39.4B
AUM Growth
+$3.78B
(+11%)
Cap. Flow
+$934M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
22.56%
Holding
1,080
New
75
Increased
361
Reduced
442
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$242M |
| 2 |
Illumina
ILMN
|
+$98.3M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$80.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Fortive
FTV
|
+$55.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.6M |
| 2 |
Mettler-Toledo International
MTD
|
+$54.4M |
| 3 |
Edwards Lifesciences
EW
|
+$47.2M |
| 4 |
Danaher
DHR
|
+$46.2M |
| 5 |
Microsoft
MSFT
|
+$45.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 17.29% |
| 3 | Financials | 13.57% |
| 4 | Consumer Discretionary | 12.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Dynatrace
DT
$12.1B
| $45M | 0.11% |
1,776,978
+1,115,717
| +169% | +$24.5M |
|
152
Sonoco
SON
$5.76B
| $44.6M | 0.11% |
721,827
-1,016
| -0.1% | -$60.1K |
|
153
Virtus Investment Partners
VRTS
$1.11B
| $44.3M | 0.11% |
363,875
+2,501
| +0.7% | +$279K |
|
154
Abbott
ABT
$180B
| $43.2M | 0.11% |
497,438
+7,607
| +2% | +$637K |
|
155
Fair Isaac
FICO
$28.7B
| $42.8M | 0.11% |
114,237
-22,820
| -17% | -$7.68M |
|
156
Pfizer
PFE
$140B
| $42.8M | 0.11% |
1,150,786
-19,200
| -2% | -$684K |
|
157
Essential Properties Realty Trust
EPRT
$6.99B
| $42.6M | 0.11% |
1,717,659
-1,775
| -0.1% | -$44.6K |
|
158
Dow Inc
DOW
$21.6B
| $42.2M | 0.11% |
771,605
-523,463
| -40% | -$27M |
|
159
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
| $42.1M | 0.11% |
1,369,116
+12,372
| +0.9% | +$363K |
|
160
Broadridge
BR
$17.2B
| $41.3M | 0.1% |
334,475
+11,369
| +4% | +$1.39M |
|
161
Mine Safety
MSA
$6.74B
| $41.1M | 0.1% |
325,070
+54,628
| +20% | +$6.57M |
|
162
Blackstone
BX
$104B
| $40.7M | 0.1% |
727,527
+148,064
| +26% | +$7.68M |
|
163
Schwab US Broad Market ETF
SCHB
$42.8B
| $39.9M | 0.1% |
3,117,342
+16,614
| +0.5% | +$204K |
|
|
ECHO
164
EchoStar
ECHO
$25.5B
| $39.7M | 0.1% |
916,396
-892
| -0.1% | -$35.8K |
|
|
GBT
165
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $39M | 0.1% |
490,192
+34,610
| +8% | +$2.05M |
|
166
Agilent Technologies
A
$39.1B
| $38.8M | 0.1% |
454,658
+446,556
| +5,512% | +$35.2M |
|
167
Assurant
AIZ
$13.7B
| $38.7M | 0.1% |
295,196
-102,483
| -26% | -$13.2M |
|
168
McGrath RentCorp
MGRC
$2.94B
| $38.6M | 0.1% |
504,867
-111,941
| -18% | -$8.12M |
|
|
BHVN
169
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $38.5M | 0.1% |
707,684
-382,308
| -35% | -$18.9M |
|
170
American Express
AXP
$223B
| $38.5M | 0.1% |
308,960
-787
| -0.3% | -$94.1K |
|
171
DuPont de Nemours
DD
$18.6B
| $38.2M | 0.1% |
473,799
-452,873
| -49% | -$37.6M |
|
172
iShares MSCI ACWI ETF
ACWI
$32.6B
| $38.1M | 0.1% |
480,619
+4,742
| +1% | +$363K |
|
173
Kadant
KAI
$3.69B
| $37.4M | 0.09% |
354,862
-1,024
| -0.3% | -$97.2K |
|
|
MGLN
174
DELISTED
Magellan Health Services, Inc.
MGLN
| $37.3M | 0.09% |
476,382
-254
| -0.1% | -$17.9K |
|
|
XEC
175
DELISTED
CIMAREX ENERGY CO
XEC
| $36.7M | 0.09% |
700,035
-41,650
| -6% | -$1.94M |
|
Similar funds
QCM
Brown Advisory's Q4 2019 Portfolio in Review
As of Q4 2019, Brown Advisory held 1,080 positions worth $39.4B, up 11% from $35.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q4 2019 filing shows 75 new, 361 increased, 442 reduced and 44 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 228,512 shares worth $84.6M. The largest sale was PayPal, an estimated $61.6M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2019 buy was Bio-Rad Laboratories Class A: 228,512 shares worth $84.6M.
- Brown Advisory added most to L3Harris in Q4 2019, an estimated $242M increase.
- Brown Advisory's biggest Q4 2019 reduction was PayPal, cutting an estimated $61.6M.
- Brown Advisory fully exited Loral Space and Communications, Inc. in Q4 2019, selling an estimated $21.1M.
- Brown Advisory's ten largest holdings make up 23% of its $39.4B portfolio in Q4 2019.
- Brown Advisory opened 75 new positions and closed 44 in Q4 2019.
- Brown Advisory's portfolio value rose 11% quarter-over-quarter to $39.4B.
Based on Brown Advisory's 13F filing for Q4 2019, filed 14 Feb 2020.